SOLESENCE, Inc. (SLSN) intrinsic value & 10-year financials
SOLESENCE, Inc. (SLSN) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 21.5% a year to $62.1M, with an average return on invested capital of -56.7%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.90
- Market cap
- $65.3M
- Revenue (FY2025)
- $62.1M
- Revenue growth (10-yr CAGR)
- 21.5%
- ROIC (10-yr avg)
- -56.7%
- Free cash flow (FY2025)
- —
SLSN 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $62.1M | $1.8M | $0.02 | — | 2.5% | 6.5% |
| FY2024 | $52.3M | $4.2M | $0.07 | -$2.6M | 9.8% | 30.5% |
| FY2023 | $37.3M | -$4.4M | -$0.09 | -$3.1M | -9.5% | -30.0% |
| FY2022 | $37.3M | -$2.6M | -$0.05 | -$4.5M | -6.1% | -13.8% |
| FY2021 | $29.5M | $2.3M | $0.05 | $447.0K | 8.7% | 21.8% |
| FY2020 | $17.1M | $989.0K | $0.03 | -$2.9M | 8.7% | 24.3% |
| FY2019 | $12.5M | -$3.0M | -$0.08 | -$3.5M | -22.4% | -163.1% |
| FY2018 | $14.2M | -$2.1M | — | -$1.5M | -14.3% | -371.2% |
| FY2017 | $12.5M | -$789.0K | — | -$1.2M | -6.2% | -25.6% |
| FY2016 | $10.8M | -$1.3M | — | -$369.0K | -11.8% | -46.0% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
SOLESENCE, INC. is a consistent compounder, expanding top-line revenue at 21.5% annually over the past decade.
SOLESENCE, INC. has historically struggled to out-earn its cost of capital, averaging just -3.8% ROIC.
SOLESENCE, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, SOLESENCE, INC. is modeled at -7.8% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.12 per share.